CNBC Fast Money Halftime Report October 9, 2017
That ges challenges are worse than anybody else in the market. They say its bod and could potentially get worse. So the problem with that kind of prognosis for shareholders is, you know, this this historically has been a orphan stock. Some people said i dont really need high returns. I feel like this company is going to endure and it will be like good enough or a market stock, and that has not been the case for a while the situation has been deteriorating. Its almost become a conglomerate, but in the negative connotation where people are saying why does this thing even exist in its current for...